About Lung-MAP: Mission and Vision
Lung-MAP Partners
Lung-MAP has been an integral part in ensuring all patients’ tumors are tested for their unique biomarkers in order to receive the right treatment, at the right time, for the right patient.
– Kim Norris, President, Lung Cancer Foundation of America
LUNG-MAP Mission
Lung-MAP aims to transform metastatic non-small cell lung cancer treatment through precision medicine, tailoring therapies to each tumor’s genetic makeup. Our mission is to enhance patient outcomes by partnering with key stakeholders to expedite innovative research and clinical application, while leveraging patient data to inform future advancements.
Lung-MAP Vision
We envision a future where personalized care for metastatic non-small cell lung cancer, rooted in precision medicine and the latest research, is accessible to all. Our goal is to continually foster a collaborative environment that fosters breakthroughs, making lung cancer a manageable condition while eliminating disparities in care and treatment outcomes.
Lung-MAP has been an integral part in ensuring all patients’ tumors are tested for their unique biomarkers in order to receive the right treatment, at the right time, for the right patient.
– Kim Norris, President, Lung Cancer Foundation of America